Cerenome (CNSY) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 93.04% |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | -25.59% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 1,170.12% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -53.46% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 99.48% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -6,389.91% |
| Mar 31, 2025 | 93.35% |
| Dec 31, 2024 | -9.96% |
| Sep 30, 2024 | -66.66% |
| Jun 30, 2024 | -929.24% |
| Mar 31, 2024 | -175.35% |
| Dec 31, 2023 | -23.96% |
| Sep 30, 2023 | -46.71% |
| Jun 30, 2023 | 48.03% |
| Mar 31, 2023 | -79.52% |
| Dec 31, 2022 | -185.46% |
| Sep 30, 2022 | -68.88% |
| Jun 30, 2022 | -127.67% |
| Mar 31, 2022 | -95.59% |
| Dec 31, 2021 | -7.22% |
| Sep 30, 2021 | -224.11% |
| Jun 30, 2021 | -43.43% |
| Mar 31, 2021 | -43.50% |
| Dec 31, 2020 | -180.14% |
| Sep 30, 2020 | -163.55% |